Boehringer Ingelheim posts Brightline-2 brigimadlin results; BI 4060107 trial recruitsOct 15Weekly roundup, 5 itemsBoehringer Ingelheimempagliflozin
Boehringer Ingelheim registers five new trials, spanning oncology, obesity, and ILD screeningOct 2Weekly roundup, 7 itemsBoehringer IngelheimempagliflozinUpdated